Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Fuji Pharma 1H Net Y713.00M Vs Net Y1.29B
Fuji Pharma Co. Ltd. (4554.TO) Japan Half-Year Ended March 31 GROUP 2026 2025 Revenue Y29.72 bln Y24.10 bln Operating Profit Y4.40 bln Y2.31 bln Pretax Profit Y4.26 bln Y2.21 bln Net Profit Y713.00 mln Y1.29 bln Per share Earnings Y28.75 Y52.83…
The Trump-Pharma deals reflect the flaws of state capitalism
Beginning in 2017, President Donald Trump has sought to implement a policy affecting drug prices now known as the “most favored nation” approach, a term borrowed from international trade agreements. The intention is to bar biopharma…
Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
Holding expects drugs it already has on the market and a trio of medicines due to be launched shortly to deliver sales growth for its pharmaceutical business through the end of the decade, its chief executive said. The Swiss drugmaker's on-market…
What to Know About This Fund's Sale of a Pharma Stock Up 56% in a Year
On May 12, 2026, Quantedge Capital disclosed in an SEC filing that it sold out its entire stake in Supernus Pharmaceuticals (SUPN +2.24%) during the first quarter, with an estimated transaction value of $4.56 million based on quarterly average…
/ciol/media/media_files/2026/05/12/ciol_-pics-9-2026-05-12-15-26-26.png)
Startup SwishX Launches Agentic AI Platform for Pharma, Raises $2.2 Million Seed Funding
Bengaluru-based startup SwishX has launched what it called the world's first Agentic AI platform built exclusively for pharmaceutical and medtech companies, as healthcare and life sciences firms increasingly turn to artificial intelligence (AI) to…
aTyr Pharma, Inc. (ATYR) Discusses FDA Feedback and Next Steps for Efzofitimod in Pulmonary Sarcoidosis After Phase III Results Transcript
aTyr Pharma, Inc. (ATYR) Discusses FDA Feedback and Next Steps for Efzofitimod in Pulmonary Sarcoidosis After Phase III Results May 11, 2026 4:30 PM EDT Ashlee Dunston - Director of Investor Relations & Corporate Communications Sanjay Shukla -…
Bristol Myers Squibb partners with China's Hengrui Pharma on a dozen drugs
Bristol Myers Squibb announced on Tuesday a partnership with Hengrui Pharma covering more than a dozen early-stage programs, the latest and a notably large case of a global pharmaceutical company looking to China for its next medicines. The…
Pharmalittle: We're reading about pharma lobbying, Bristol's deal with a Chinese partner, and more
Top of the morning to you, and a fine one it is. Sunny skies and mild breezes are enveloping the Pharmalot campus once again. Who could ask for anything more? Actually, we could. Specifically, we would like another cup of stimulation. So off we go…
Torrent Pharma says JB Chemicals merger in final phase, expects completion in 1-2 months
Torrent Pharmaceuticals said the merger process of Mumbai-based JB Chemicals & Pharmaceuticals Ltd with the company has entered its final stage, with a hearing scheduled in the second week of June and the transaction expected to become effective…
New reporting links skepticism of the vitamin K shot to newborn deaths. Influencers and media figures have been fearmongering about the shot for years.
Alex Jones of the now-defunct site Infowars: “They try to give them a vitamin K shot at birth to thicken the blood quicker. That's got a lot of issues with it.” He added of vaccines generally, “It really messes little babies up…
Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Bristol-Myers Squi
Bristol-Myers Squibb Co. (NYSE:) on Tuesday announced a partnership with Hengrui Pharma to develop a portfolio of 13 early-stage programs spanning oncology, hematology and immunology. The deal follows the company's earlier success with Sotyktu, an…
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in…
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
aTyr Pharma NASDAQ: ATYR said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C meeting. President and CEO Dr. Sanjay Shukla said…
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM Co-founder and CEO, Dr Andrea Pfeifer, to retire after a distinguished 23-year tenure Board Chair, Martin Zügel, MD, to be appointed interim CEO Dr Pfeifer to serve as an…
Orion Animal Health receives US FDA approval for Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
Orion Animal Health receives US FDA approval for Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs Orion Corporation today announced that on 6 May 2026 the U.S. Food and Drug Administration (FDA)…
Receive a Daily briefing on Pharma Industry News
Get Started